Testing of standard drugs for mycobacterium tuberculosis (MTB) in animal models for MTB
Ended Awarded Last action
- Contract number
- 75N93021F00003
- Awardee
-
University Of Texas Medical Branch At Galveston UEI MSPWVMXXMN76 Part of University Of Texas System
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $347,684
Award facts
- Opportunity
-
- 75N93021F00003 Solicitation number
- Contract value 100% obligated
- $347,683.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Galveston, TX 77555, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$24,914 | |
| Other Administrative Action | $0 | |
| Original award | $372,598 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to University of Texas Medical Branch At Galveston on August 15, 2021, with a ceiling value of $347,683.71 under the Preclinical Services for HIV Therapeutics parent IDIQ for testing of standard drugs for Mycobacterium tuberculosis in animal models.
Place of performance is Galveston, TX. The order carried an ultimate completion date of June 14, 2022 and was issued on a cost-plus-fixed-fee basis to de-obligate unexpiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a).
Service Contract Inventory reporting for fiscal year 2022 reflects $348 thousand invoiced across 1.7 FTEs and 3,596 contractor hours, with a derived government-paid rate of $96.70 per hour. The awardee self-performed all reported labor; no subcontractors were engaged.
Quick answers
Who was awarded contract 75N93021F00003?
75N93021F00003 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 15, 2021.
How much is contract 75N93021F00003 worth?
The government has obligated $347,684 on 75N93021F00003.
Is contract 75N93021F00003 an order under another contract?
Yes. 75N93021F00003 is a delivery order under 75N93021D00011, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.
Was contract 75N93021F00003 competed?
The extent of competition for 75N93021F00003 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award